AMRX

Amneal Pharmaceuticals INC

+$36.9M

Net Activity

Institutions Holding

314

Popularity Rank

#1899

Avg Weight

0.09%

Total Value

$2.0B

Ownership Trend

314 institutions currently hold AMRX, with 186 net buyers and 117 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

117

Net Buying Institutions

186

Key Holders

View all 314 holding institutions

Quarterly Activity

Recent Activity

+$1.1B

Total Buy Value

$769.8M

Total Sell Value

New buy70
Trim79
Add116
Sold out38

186

Net Buyers

117

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AMNEAL PHARMACEUTICALS INC (AMRX)?
Major stakeholders currently include BlackRock, Inc. ($304.8M), Tpg Gp A, LLC ($153.2M), Vanguard Portfolio Management LLC ($140.8M). Based on the latest 13F filings, there are a total of 314 tracked investment funds and institutions maintaining positions in AMRX.
What is the overall institutional sentiment toward AMRX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $36.9M, driven by 186 managers accumulating shares while 117 reduced their exposure.
Which institutions have been selling or reducing their AMRX positions?
In the latest period, 79 funds trimmed their holdings, and 38 managers completely exited their positions. The aggregate reported sell value was $769.8M.
Are there any notable investors adding AMRX to their portfolios?
Yes, buying activity remains notable. 70 institutions opened new positions in {ticker}, and 116 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.1B.

Related Stocks